For research use only — not for human consumption

Senna Research
← Back to catalog
GLP1 SEMA + Cagrilintide research vial

Metabolic Research

In stock

GLP1 SEMA + Cagrilintide

GLP-1 Sema + Cagrilintide is a peptide combination studied in research models for coordinated incretin and amylin receptor signaling [1,2] .

Professional pricing

Sign in or create a research account to see prices and add this material to your order. Access unlocks as soon as you create your account.

Sign in for pricing
  • In stock — ready to ship
  • Controlled handling
Shipment issuesWe do not accept returns on released material. Wrong item, damage, or a missing package is resolved directly.

Specifications

Product & molecular data

Lot & handling

SKU
SR-2247
Category
Metabolic Research
Storage
-20 °C, sealed, protected from light
Availability
In stock

Molecular

Sequence
Not available
Molecular formula
Not available
Molecular weight
Not available
CAS number
N/A
Storage conditions
−20 °C sealed and desiccated, protected from light
Format
Lyophilized Vial

Analytics

Testing & quality

When a lot certificate is on file we report identity, purity, and appearance. We publish analytical data only — never dosing information or outcome claims.

01

RP-HPLC

Chromatographic purity against a qualified reference standard.

02

LC-MS / ESI-MS

Identity by observed versus theoretical molecular mass.

03

Karl Fischer / Loss on Drying

Residual moisture in lyophilized material.

04

Endotoxin & Bioburden

Contaminant screening on raw material and finished lots.

Read the Quality Statement →

Research background

Published research context

Summary of the published literature this reference material is used in.

01

Telomere Biology

Investigated in cell-culture models of telomere maintenance and replicative ageing.

02

Gene Expression

Studied for reported effects on transcriptional regulation in experimental systems.

03

Senescence Models

Referenced in literature examining cellular senescence markers in vitro.

Dual-Pathway Signaling

Semaglutide targets GLP-1 receptors, while cagrilintide is an amylin analog [1]. Combined studies examine coordinated receptor activation and pathway timing.

Appetite and Energy Regulation

Research explores how incretin and amylin signaling intersect in metabolic and appetite-related pathways [2].

Combination Design Rationale

Peptide combinations allow researchers to assess pathway synergy and receptor cross-modulation under controlled conditions [1].

Key Specs

  • Combo type: GLP-1 + amylin analog
  • Research context: metabolic signaling
  • References: PubMed [1,2]

Referenced Citations

  1. PubMed, Cagrilintide and GLP-1 combinations: https://pubmed.ncbi.nlm.nih.gov/34450248/
  2. PubMed, Amylin and incretin signaling: https://pubmed.ncbi.nlm.nih.gov/19640841/

Related compounds

Mandatory research disclaimer

All materials on this site are sold as laboratory reagents for research use only. They are not drugs, foods, cosmetics, dietary supplements, or medical devices, and are not for human or veterinary use of any kind.

Senna Research makes no claims of safety or efficacy and provides no usage, dosing, or preparation guidance; we publish analytical data only.

These materials have not been evaluated or approved by the U.S. Food and Drug Administration for any use.